New heart shunt device could ease heart failure symptoms
NCT ID NCT04000607
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a device called the APTURE shunt, which is implanted in the heart to create a small passage that may help relieve pressure. It involves 45 people with symptomatic heart failure who are already on standard medications. The goal is to see if the device is safe and can improve symptoms and reduce the need for hospital care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
APTURE transcatheter shunt system (a device implanted in the heart to create a small passage between chambers)
What this could lead to
If it works, this device could offer a new way to relieve pressure in the heart and improve symptoms for people with heart failure, potentially reducing hospital stays.
What could go wrong
This is an early exploratory study with only 45 participants, so results may not apply to everyone. There are risks from the implant procedure, including heart, brain, or kidney complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
-
University of Ottawa Heart Institute
Ottawa, Ontario, Canada